Transform Materials Achieves Milestone In Commercial-Scale Pilot plant to Produce Hydrogen

By May 12, 2021 3   min read  (498 words)

May 12, 2021 |

Fuel cells works, hydrogen, Transform materials

Manufacturing process for Transform Materials’ revolutionary technology in key chemical products validated at pilot plant; Transform and DSM Nutritional Products begin discussions for global-scale commercial production.

RIVIERA BEACH, Florida – Transform Materials LLC (“Transform”), a sustainable chemical company with a patented net-carbon-negative process to cost-effectively produce commercial acetylene and hydrogen, has announced a milestone in scaling its global production capability.

Transform in alignment with its licensing partner, DSM Nutritional Products Ltd (“DSM”), part of Netherlands-based Royal DSM with global products and services in nutrition, health and sustainable living, declare the successful operation of Transform’s pilot chemical plant in Riviera Beach, Fla., which paves the way for the development of large-scale commercial production. Transform conducted more than 6 months of testing and evaluation to complete and meet the rigorous milestone targets proving a 99% operational uptime.

Under the licensing agreement, Transform has granted DSM certain rights to Transform’s patented technology when used in the production of vitamins, carotenoids and nutritional ingredients. DSM’s Improve, Enable, Advocate strategy aims to enable low-carbon energy solutions that support the transition to a low carbon economy and at the same time offers further greenhouse gas (GHG) reduction opportunities for customers.

“Taking responsible action on climate change and reducing our carbon footprint is a key value driver for our company,” says Ronald Gebhard, VP of Process Innovation of DSM Nutritional Products. “Transform’s net-carbon-negative process is a game-changer in the development of renewable acetylene and hydrogen, key products used in so many industries and typically produced at higher cost and with high carbon emissions. For us, Transform’s process is an important green technology that fits well into our portfolio to continue to implement our business strategy to be purpose-led and performance-driven.”

Founded in 2014, Transform accelerated its commercialization strategy in 2020 and is generating significant interest from customers whose processes require a ready, green, and cost-advantageous source of hydrogen or acetylene. Hydrogen is a free-standing clean energy source as well as a key ingredient for many industrial sectors, such as ammonia synthesis, oil refining, fine chemicals, electronics, and metallurgy. Acetylene is an important and highly reactive precursor for producing high-value products such as vitamins, fragrances and flavors, carbon solids, and high-utility polymers that can be used for personal-care products and structural materials. Transform has already developed a large project pipeline with prospective blue-chip customers in North America and in Europe.

“We are seeing tremendous interest from top-tier commercial customers for both of our marketable products: the high-purity hydrogen and the chemical-grade acetylene, both generated with very low carbon emissions at a lower cost point than current technology,” said Stuart Jara, CEO of Transform. “We’re excited about our partnership with DSM and the momentum that Transform continues to demonstrate in 2021.”

Following the milestone achievement of the pilot plant, Transform and DSM Nutritional Products are now in discussions on how to integrate the Transform technology into its manufacturing network to support DSM’s continued growth as the leading global producer of sustainable vitamins, carotenoids, and nutritional ingredients.


Author FuelCellsWorks

More posts by FuelCellsWorks
error: Alert: Content is protected !!